【大摩:降国药控股(01099.HK)目标价至22.5港元 评级“增持”】智通财经APP获悉,大摩发布研报称,将国药控股

智通财经
15 Jul
【大摩:降国药控股(01099.HK)目标价至22.5港元 评级“增持”】智通财经APP获悉,大摩发布研报称,将国药控股(01099.HK)2025至2030年盈利预测下调1%至6%,原因是医疗设备和药物分销部门的销售额预测被下调。目标价由23港元降至22.5港元,评级增持。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10